roomsetr.blogg.se

G2a carrier command 2
G2a carrier command 2











g2a carrier command 2

239000002246 antineoplastic agent Substances 0.000 claims description 39.230000008313 sensitization Effects 0.000 claims description 40.206010070834 Sensitisation Diseases 0.000 claims description 40.BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 48.ZROHGHOFXNOHSO-BNTLRKBRSA-L (1R,2R)-cyclohexane-1,2-diamine oxalate platinum(2+) Chemical group ZROHGHOFXNOHSO-BNTLRKBRSA-L 0.000 claims description 48.150000002632 lipids Chemical class 0.000 claims description 63.NPDSHTNEKLQQIJ-ZJHFMPGASA-N α-dimorphecolic acid Chemical compound CCCCC\C=C/C=C/C(O)CCCCCCCC(O)=O NPDSHTNEKLQQIJ-ZJHFMPGASA-N 0.000 claims description 66.

g2a carrier command 2

  • 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 15.
  • 230000003405 preventing Effects 0.000 title claims abstract description 14.
  • 208000004296 Neuralgia Diseases 0.000 title claims abstract description 30.
  • 238000002512 chemotherapy Methods 0.000 title claims abstract description 36.
  • 239000003112 inhibitor Substances 0.000 title claims abstract description 114.
  • 230000002401 inhibitory effect Effects 0.000 title claims abstract description 152.
  • filed Critical Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from EP16190362.0 external-priority Application filed by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Priority date (The priority date is an assumption and is not a legal conclusion. Inventor Susanne SCHIFFMANN Klaus Scholich Gerd Geisslinger Stephan HOHMANN Marco Sisignano Original Assignee Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Google Patents WO2018055082A1 - Inhibitors of gpr132 for use in preventing and/or treating chemotherapy-induced neuropathic pain

    g2a carrier command 2

    WO2018055082A1 - Inhibitors of gpr132 for use in preventing and/or treating chemotherapy-induced neuropathic pain













    G2a carrier command 2